Search results for "Highlights"
Association of inflammation with mortality in COVID-19 didn't differ by diabetes status
A single-center, case-control study of patients who were hospitalized with COVID-19 found a link between elevated levels of IL-6, IL-8, and interferon-γ-induced protein 10 and mortality risk, regardless of whether patients had type 2 diabetes.
https://diabetes.acponline.org/archives/2022/01/14/2.htm
14 Jan 2022
Neurologists update guideline on treatment of painful diabetic neuropathy
The updated guideline from the American Academy of Neurology supports offering tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, gabapentinoids, and/or sodium channel blockers to reduce pain from diabetic neuropathy.
https://diabetes.acponline.org/archives/2022/01/14/1.htm
14 Jan 2022
Study finds long-term reductions in cardiovascular risk factors with SGLT-2 inhibitors
While the meta-analysis also found durable reductions in macrovascular complications and mortality with sodium-glucose cotransporter-2 (SGLT-2) inhibitors versus placebo, there were insufficient data comparing the drug class to other antihyperglycemic medications.
https://diabetes.acponline.org/archives/2021/12/10/2.htm
10 Dec 2021
Adults with diabetes more likely to report mental stress during the COVID-19 pandemic
An online survey of U.S. adults in mid-2020, most of whom were White women, found that those with diabetes were less likely to report resilience and more likely to experience depression than adults without diabetes.
https://diabetes.acponline.org/archives/2021/12/10/3.htm
10 Dec 2021
Hospitalizations for diabetes complications fell, were replaced by other causes
An analysis of excess hospitalizations among people with diabetes in England from 2003 to 2018 found that diabetes caused fewer of their hospital stays, with respiratory disease and cancer becoming more predominant diagnoses.
https://diabetes.acponline.org/archives/2021/12/10/1.htm
10 Dec 2021
Spotlight on dementia and glycemic control
Prediabetes and diabetes were associated with development of dementia in a South Korean study, and poorly controlled diabetes was tied to increased risk of incident cognitive impairment or progression to dementia in a Swedish study.
https://diabetes.acponline.org/archives/2021/11/12/5.htm
12 Nov 2021
No long-term disruption of glycemic control seen after COVID-19, study finds
The authors of a small Italian study of hospitalized COVID-19 patients speculated that reversible transient factors, such as inflammation-induced insulin resistance, may cause the hyperglycemia that occurs in some patients with and without diabetes during infection.
https://diabetes.acponline.org/archives/2021/11/12/2.htm
12 Nov 2021
Rates of hypoglycemic, hyperglycemic crises high in patients with diabetes and ESKD
The results of a retrospective study of U.S. data in patients with both diabetes and end-stage kidney disease (ESKD) indicate that current glycemic monitoring and treatment in this population are suboptimal, the authors said.
https://diabetes.acponline.org/archives/2021/11/12/3.htm
12 Nov 2021
Nearly 5% of adults diagnosed with type 2 diabetes in Scotland were in remission in 2019
Compared with people who did not achieve remission, those in remission tended to be older, to have a lower HbA1c level at diagnosis, to have never taken any glucose-lowering medication, to have lost weight since diabetes diagnosis, and to have had bariatric surgery.
https://diabetes.acponline.org/archives/2021/11/12/1.htm
12 Nov 2021
Type 1 and type 2 diabetes associated with increased risk of herpes zoster
Results of a systematic review and meta-analysis were consistent across age groups, diabetes types, and regions of the world. The study authors suggested that earlier vaccination against herpes zoster in all patients with diabetes, regardless of age, be considered.
https://diabetes.acponline.org/archives/2021/10/08/2.htm
8 Oct 2021